| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 10 |
| 1 | ADALIMUMAB-AATY | 9 |
| 2 | ADALIMUMAB-ADAZ | 9 |
| 3 | ADALIMUMAB-FKJP | 9 |
| 4 | ETANERCEPT | 4 |
| 5 | LAMIVUDINE | 3 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE | 3 |
| 7 | URSODIOL | 3 |
| 8 | BIMATOPROST | 2 |
| 9 | EFAVIRENZ | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-AUUB | 1 | 0.0057 |
| 1 | ACITRETIN | 1 | 0.0002 |
| 2 | ADALIMUMAB-FKJP | 9 | 0.0002 |
| 3 | ADALIMUMAB-AATY | 9 | 0.0002 |
| 4 | EFAVIRENZ | 2 | 0.0002 |
| 5 | ADALIMUMAB-ADAZ | 9 | 0.0002 |
| 6 | URSODIOL | 3 | 0.0001 |
| 7 | LAMIVUDINE | 3 | 0.0001 |
| 8 | BIMATOPROST | 2 | 0.0001 |
| 9 | BICALUTAMIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bile Acid [EPC] | 3 | 0.0001 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 3 | Prostaglandin Analog [EPC] | 3 | 0.0000 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 12 | 0.0000 |
| 8 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |